| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 27 | 0.457 | 0.808 | 0.78 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
pre-mRNA processing factor 31 | 0.531 | 0.731 | 0.98 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
stimulator of interferon response cGAMP interactor 1 | 0.522 | 0.769 | 1.2E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
CD82 molecule | 0.507 | 0.731 | 1.3E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | ||||||||
|
potassium calcium-activated channel subfamily M alpha 1 | 0.518 | 0.846 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
MAX dimerization protein 1 | 0.564 | 0.692 | 0.23 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
matrix metallopeptidase 12 | 0.484 | 0.885 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | |||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1995 | 1995 | ||||||||
|
interleukin 17D | 0.464 | 0.808 | 0.20 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
myeloid derived growth factor | 0.451 | 0.846 | 3.5E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
dihydropyrimidinase like 5 | 0.644 | 0.500 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
pyridoxal phosphatase | 0.533 | 0.731 | 0.26 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
microRNA 505 | 0.603 | 0.577 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | |||||||||
|
RAP2C, member of RAS oncogene family | 0.890 | 0.038 | 0.30 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
leucine rich repeat containing 4 | 0.617 | 0.577 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
loss of heterozygosity, 19, chromosomal region 1 | 0.569 | 0.808 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2002 | 2002 | |||||||||
|
eukaryotic translation initiation factor 3 subunit H | 0.700 | 0.308 | 4.7E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
carbonyl reductase 3 | 0.736 | 0.385 | 3.0E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
carbohydrate sulfotransferase 2 | 0.760 | 0.269 | 1.8E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
natural cytotoxicity triggering receptor 2 | 0.656 | 0.538 | 2.5E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
natural cytotoxicity triggering receptor 1 | 0.572 | 0.654 | 7.3E-11 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.050 | None | 0.400 | 5 | 0 | 2004 | 2016 | ||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
disease | 0.060 | None | 0.500 | 6 | 0 | 2004 | 2016 | ||||||||
|
C-X-C motif chemokine receptor 3 | 0.436 | 0.808 | 0.18 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2009 | 2019 |